muscle toxicity
Showing 1 - 25 of >10,000
Glucocorticoids Toxicity, Iatrogenic Effect Trial (Prednisolone, Placebo)
Not yet recruiting
- Glucocorticoids Toxicity
- Iatrogenic Effect
- Prednisolone
- Placebo
- (no location specified)
Nov 21, 2023
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Aug 24, 2022
Toxicity Trial in Ghent (Adjuvant EBRT)
Completed
- Toxicity
- Adjuvant EBRT
-
Ghent, BelgiumDept of Radiotherapy, University Hospital Ghent
Dec 23, 2022
Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)
Not yet recruiting
- Muscle Invasive Bladder Urothelial Carcinoma
- Daily Adaptive External Beam Radiation Therapy
-
Saint Louis, MissouriWashington University, St. Louis
Jan 17, 2023
Mitochondrial dysfUnction:Key Player in Doxorubicin-induced
Not yet recruiting
- Doxorubicin Induced Cardiomyopathy
- +3 more
- 31-MRS at 7 Tesla (T)
-
Utrecht, Netherlands
- +1 more
Feb 7, 2023
Muscle-Invasive Bladder Carcinoma Trial in Herlev (Varian Ethos Adaptive Radiation Therapy)
Recruiting
- Muscle-Invasive Bladder Carcinoma
- Varian Ethos Adaptive Radiation Therapy
-
Herlev, DenmarkHerlev and Gentofte Hospital
Nov 29, 2022
Non-muscle Invasive Bladder Cancer Trial in Hanover, Mount Laurel, Rochester (TARA-002)
Recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
-
Los Angeles, California
- +11 more
Jan 31, 2023
Colorectal Cancer, Chemotherapeutic Toxicity, Survivorship Trial in Nijmegen, Utrecht (Continuous aerobic and resistance
Recruiting
- Colorectal Cancer
- +3 more
- Continuous aerobic and resistance exercise intervention
- Continuous aerobic and aerobic interval exercise intervention
-
Almere, Netherlands
- +11 more
Oct 25, 2022
Testicular Germ Cell Tumor Trial in Bratislava (aerobic-strength exercise intervention (6-months))
Active, not recruiting
- Testicular Germ Cell Tumor
- aerobic-strength exercise intervention (6-months)
-
Bratislava, Please Select, Slovakia
- +1 more
Sep 21, 2021
Impact of Low Muscle Mass in HNC Treated With Immunotherapy
Recruiting
- Head and Neck Small Cell Carcinoma
- Sarcopenia
-
L'Hospitalet De Llobregat, Barcelona, SpainInstitut Catala d'Oncologia
Jan 21, 2021
Toxicodynamics of Daptomycin in Bone and Joint Infections
Recruiting
- Dactinomycin Adverse Reaction
- Bone and Joint Infection
- patients having had BJI or PJI treated with daptomycin
-
Lyon, FranceHospices Civils de Lyon
May 5, 2022
Muscle Dysfunction in Hematological Diseases Referred to Stem
Not yet recruiting
- Hematologic Diseases
- +7 more
- No intervention
-
Copenhagen, DenmarkRigshospitalet
Nov 15, 2019
Lung Cancer, Sarcopenia Trial in Beijing (soy protein, whey protein, )
Not yet recruiting
- Lung Cancer
- Sarcopenia
- soy protein
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 5, 2023
Gynecologic Cancer Trial (Experimental product - Fortifit® Powder, Standard of care)
Not yet recruiting
- Gynecologic Cancer
- Experimental product - Fortifit® Powder
- Standard of care
- (no location specified)
Oct 14, 2023
Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine
- +2 more
- (no location specified)
Sep 9, 2022
Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy
Recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- cisplatin based neoadjuvant chemotherapy
- Radical cystectomy alone
-
Rome, ItalyRiccardo Mastroianni
Mar 8, 2023
Effectiveness in Ovarian Cancer
Completed
- Ovarian Cancer
- +5 more
- Baseline Biopsy
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
Bladder Cancer Trial in Athens (Durvalumab)
Active, not recruiting
- Bladder Cancer
- Durvalumab
-
Athens, Attica, GreeceHellenic GenitoUrinary Cancer Group
Mar 22, 2022
Regional Anesthesia Morbidity, Arthropathy of Hip, Hip Arthropathy Trial in Cinisello Balsamo (PENG plus LFCN block, FIC Block)
Recruiting
- Regional Anesthesia Morbidity
- +4 more
- PENG plus LFCN block
- FIC Block
-
Cinisello Balsamo, Milano, ItalyOspedale Edoardo Bassini
Nov 24, 2023
Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)
Not yet recruiting
- Urothelial Bladder Carcinoma
- Sacituzumab govitecan
- +2 more
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Nov 14, 2023
Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating
Recruiting
- Urothelial Carcinoma
- Non-Invasive Bladder Urothelial Carcinoma
- Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
-
Tampa, FloridaMoffitt Cancer Center
Mar 2, 2023
Muscle-Invasive Bladder Carcinoma, Oligometastatic Disease Trial (metastasis directed therapy (MDT), Immunotherapy)
Recruiting
- Muscle-Invasive Bladder Carcinoma
- Metastasis directed therapy (MDT)
- +2 more
-
Ghent, BelgiumGhent University Hospital
Dec 3, 2022
Multiple Sclerosis Trial in Istanbul (Inspiratory Muscle Training, Balance Exercises)
Recruiting
- Multiple Sclerosis
- Inspiratory Muscle Training
- Balance Exercises
-
Istanbul, Şişli, TurkeyProf. Dr. Cemil Taşçıoğlu Şehir Hastanesi
Oct 4, 2023
Breast Tumors Trial in Granada (ATOPE-B, ATOPE-I)
Recruiting
- Breast Neoplasms
- ATOPE-B
- ATOPE-I
-
Granada, SpainUniversity of Granada
May 25, 2022